Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Moons

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmacogenomics|August 17, 2011
Relationship between P-glycoprotein and second-generation antipsychoticsTim Moons, Mariska de Roo, Stephan Claes, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
CNR1 gene and risk of the metabolic syndrome in patients with schizophreniaWeiping Yu, Marc De Hert, Tim Moons, et al.
Journal of the Neurological Sciences|December 3, 2014
Single-subject classification of schizophrenia patients based on a combination of oddball and mismatch evoked potential paradigmsJorne Laton, Jeroen Van Schependom, Jeroen Gielen, et al.
Pharmacogenomics|June 24, 2014
No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sampleTim Moons, Marc De Hert, Gunther Kenis, et al.
International Clinical Psychopharmacology|June 5, 2010
MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational studyRuud van Winkel, Tim Moons, Odette Peerbooms, et al.
Plos One|March 31, 2016
Genetic Evaluation of Schizophrenia Using the Illumina HumanExome ChipTim Moons, Marc De Hert, Edith Gellens, et al.
Schizophrenia Research|November 6, 2010
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugsTim Moons, Stephan Claes, Gerard J M Martens, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 30, 2017
Gene-based interaction analysis shows GABAergic genes interacting with parenting in adolescent depressive symptomsEvelien Van Assche, Tim Moons, Ozan Cinar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmacogenomics|August 17, 2011
Relationship between P-glycoprotein and second-generation antipsychoticsTim Moons, Mariska de Roo, Stephan Claes, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
CNR1 gene and risk of the metabolic syndrome in patients with schizophreniaWeiping Yu, Marc De Hert, Tim Moons, et al.
Journal of the Neurological Sciences|December 3, 2014
Single-subject classification of schizophrenia patients based on a combination of oddball and mismatch evoked potential paradigmsJorne Laton, Jeroen Van Schependom, Jeroen Gielen, et al.
Pharmacogenomics|June 24, 2014
No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sampleTim Moons, Marc De Hert, Gunther Kenis, et al.
International Clinical Psychopharmacology|June 5, 2010
MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational studyRuud van Winkel, Tim Moons, Odette Peerbooms, et al.
Plos One|March 31, 2016
Genetic Evaluation of Schizophrenia Using the Illumina HumanExome ChipTim Moons, Marc De Hert, Edith Gellens, et al.
Schizophrenia Research|November 6, 2010
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugsTim Moons, Stephan Claes, Gerard J M Martens, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 30, 2017
Gene-based interaction analysis shows GABAergic genes interacting with parenting in adolescent depressive symptomsEvelien Van Assche, Tim Moons, Ozan Cinar, et al.
Pageof 1